Cargando…

Co-Targeting PIM Kinase and PI3K/mTOR in NSCLC

SIMPLE SUMMARY: PIM kinases interact with major oncogenic players, including the PI3K/Akt pathway, and provide an escape mechanism leading to drug resistance. This study examined PIM kinase expression in NSCLC and the potential of PIM1 as a prognostic marker. The effect on cell signaling of novel pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moore, Gillian, Lightner, Clara, Elbai, Samira, Brady, Lauren, Nicholson, Siobhan, Ryan, Ronan, O’Sullivan, Katie E., O’Byrne, Kenneth J., Blanco-Aparicio, Carmen, Cuffe, Sinead, O’Neill, Michael, Heavey, Susan, Finn, Stephen P., Gately, Kathy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125027/ https://www.ncbi.nlm.nih.gov/pubmed/33946744 http://dx.doi.org/10.3390/cancers13092139

Ejemplares similares

In pursuit of synergy: An investigation of the PI3K/mTOR/MEK co-targeted inhibition strategy in NSCLC
por: Heavey, Susan, et al.
Publicado: (2016)

Development and characterisation of a panel of phosphatidylinositide 3-kinase – mammalian target of rapamycin inhibitor resistant lung cancer cell lines
por: Heavey, Susan, et al.
Publicado: (2018)

Targeting the cancer stem cell marker, aldehyde dehydrogenase 1, to circumvent cisplatin resistance in NSCLC
por: MacDonagh, Lauren, et al.
Publicado: (2017)

PIM kinase inhibition: co-targeted therapeutic approaches in prostate cancer
por: Luszczak, Sabina, et al.
Publicado: (2020)

An Analysis of JADE2 in Non-Small Cell Lung Cancer (NSCLC)
por: Murphy, Ciara, et al.
Publicado: (2023)

Targeting Nuclear Factor-Kappa B to Overcome Resistance to Chemotherapy
por: Godwin, P., et al.
Publicado: (2013)

Cost-Efficient and Easy to Perform PCR-Based Assay to Identify Met Exon 14 Skipping in Formalin-Fixed Paraffin-Embedded (FFPE) Non-Small Cell Lung Cancer (NSCLC) Samples
por: O’Brien, Odharnaith, et al.
Publicado: (2019)

MicroRNA expression profiling and biomarker validation in treatment-naïve and drug resistant non-small cell lung cancer
por: MacDonagh, Lauren, et al.
Publicado: (2021)

Preclinical evaluation of a novel triple-acting PIM/PI3K/mTOR inhibitor, IBL-302, in breast cancer
por: Kennedy, Sean P., et al.
Publicado: (2020)

Protein Tyrosine Phosphatase Non-Receptor 11 (PTPN11/Shp2) as a Driver Oncogene and a Novel Therapeutic Target in Non-Small Cell Lung Cancer (NSCLC)
por: Richards, Cathy E., et al.
Publicado: (2023)

Exploitation of the vitamin A/retinoic acid axis depletes ALDH1-positive cancer stem cells and re-sensitises resistant non-small cell lung cancer cells to cisplatin
por: MacDonagh, Lauren, et al.
Publicado: (2021)

Examination of thromboxane synthase as a prognostic factor and therapeutic target in non-small cell lung cancer
por: Cathcart, Mary-Clare, et al.
Publicado: (2011)

Altered expression of ACOX2 in non-small cell lung cancer
por: Sui, Jane S. Y., et al.
Publicado: (2022)

Anti‐tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL‐302 in neuroblastoma
por: Mohlin, Sofie, et al.
Publicado: (2020)

Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer
por: Luszczak, Sabina, et al.
Publicado: (2020)

Treatment Strategies for KRAS-Mutated Non-Small-Cell Lung Cancer
por: O’Sullivan, Éabha, et al.
Publicado: (2023)

The role of PIM1/PIM2 kinases in tumors of the male reproductive system
por: Jiménez-García, Manuel Pedro, et al.
Publicado: (2016)

Author Correction: Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer
por: Luszczak, Sabina, et al.
Publicado: (2020)

How Autism Assistance Canines Enhance the Lives of Autistic Children
por: Morgan, Sinéad, et al.
Publicado: (2023)

USO1 expression is dysregulated in non-small cell lung cancer
por: Keogh, Anna, et al.
Publicado: (2022)

Anti-cancer effects of baicalein in non-small cell lung cancer in-vitro and in-vivo
por: Cathcart, Mary-Clare, et al.
Publicado: (2016)

International partnerships in telehealth: healthcare, industry and education
por: Finn, Frances Louise, et al.
Publicado: (2012)

High-Plex and High-Throughput Digital Spatial Profiling of Non-Small-Cell Lung Cancer (NSCLC)
por: Monkman, James, et al.
Publicado: (2020)

Inflammation and stem markers association to PIM1/PIM2 kinase-induced tumors in breast and uterus
por: Jiménez-García, Manuel-Pedro, et al.
Publicado: (2017)

Crisis change management during COVID-19 in the elective orthopaedic hospital: Easing the trauma burden of acute hospitals
por: Gibbons, John P., et al.
Publicado: (2021)

Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC)
por: O’Leary, Connor, et al.
Publicado: (2020)

Liquid Biopsy: A Multi-Parametric Analysis of Mutation Status, Circulating Tumor Cells and Inflammatory Markers in EGFR-Mutated NSCLC
por: Barr, Martin P., et al.
Publicado: (2022)

Targeting the Pim kinases in multiple myeloma
por: Keane, N A, et al.
Publicado: (2015)

Dasatinib Treatment Increases Sensitivity to c-Met Inhibition in Triple-Negative Breast Cancer Cells
por: Gaule, Patricia, et al.
Publicado: (2019)

Activation and cleavage of SASH1 by caspase-3 mediates an apoptotic response
por: Burgess, Joshua T, et al.
Publicado: (2016)

Anti‐tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL‐302 in neuroblastoma
por: Mohlin, Sofie, et al.
Publicado: (2019)

The Use of Three-Dimensional DNA Fluorescent In Situ Hybridization (3D DNA FISH) for the Detection of Anaplastic Lymphoma Kinase (ALK) in Non-Small Cell Lung Cancer (NSCLC) Circulating Tumor Cells
por: Kulasinghe, Arutha, et al.
Publicado: (2020)

Hierarchical Control on Polyene Macrolide Biosynthesis: PimR Modulates Pimaricin Production via the PAS-LuxR Transcriptional Activator PimM
por: Santos-Aberturas, Javier, et al.
Publicado: (2012)

Vascular endothelial growth factor is an autocrine growth factor, signaling through neuropilin-1 in non-small cell lung cancer
por: Barr, Martin P, et al.
Publicado: (2015)

Correction to: Vascular endothelial growth factor is an autocrine growth factor, signaling through neuropilin-1 in non-small cell lung cancer
por: Barr, Martin P., et al.
Publicado: (2020)

Long Non-Coding RNAs: Key Regulators of Epithelial-Mesenchymal Transition, Tumour Drug Resistance and Cancer Stem Cells
por: Heery, Richard, et al.
Publicado: (2017)

Linac4 PIMS
por: Pantelia, Anna
Publicado: (2014)

Fetal and maternal outcomes after maternal biologic use during conception and pregnancy: A systematic review and meta‐analysis
por: O'Byrne, Laura J., et al.
Publicado: (2022)

Allergen-induced airway inflammation and its therapeutic intervention
por: O'Byrne, Paul M
Publicado: (2009)

Multicenter validation of PIM3 and PIM2 in Brazilian pediatric intensive care units
por: Genu, Daniel Hilário Santos, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_inai1tn4v4icqnp5u8dctigch6